Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.245 EUR
499.00 M EUR
19.45 B EUR
199.03 M
About FRESEN.MED.CARE KGAA O.N.
Sector
Industry
CEO
Helen Giza
Website
Headquarters
Bad Homburg
Founded
2006
ISIN
DE0005785802
FIGI
BBG000DHYYF9
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
F
US35805BAA61
FreMedCarUSFin3 3,75% 15/06/2029 Rule 144AYield to maturity
5.40%
Maturity date
Jun 15, 2029
F
FMS5184425
Fresenius Medical Care US Finance III, Inc. 3.0% 01-DEC-2031Yield to maturity
5.17%
Maturity date
Dec 1, 2031
F
FMS5184423
Fresenius Medical Care US Finance III, Inc. 1.875% 01-DEC-2026Yield to maturity
5.17%
Maturity date
Dec 1, 2026
Explore more bonds
Frequently Asked Questions
The current price of FME is 40.670 EUR — it has increased by 1.98% in the past 24 hours. Watch FRESEN.MED.CARE KGAA O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HAN exchange FRESEN.MED.CARE KGAA O.N. stocks are traded under the ticker FME.
FME stock has risen by 3.96% compared to the previous week, the month change is a 10.70% rise, over the last year FRESEN.MED.CARE KGAA O.N. has showed a 14.98% increase.
We've gathered analysts' opinions on FRESEN.MED.CARE KGAA O.N. future price: according to them, FME price has a max estimate of 50.00 EUR and a min estimate of 29.00 EUR. Watch FME chart and read a more detailed FRESEN.MED.CARE KGAA O.N. stock forecast: see what analysts think of FRESEN.MED.CARE KGAA O.N. and suggest that you do with its stocks.
FME stock is 1.94% volatile and has beta coefficient of 0.90. Track FRESEN.MED.CARE KGAA O.N. stock price on the chart and check out the list of the most volatile stocks — is FRESEN.MED.CARE KGAA O.N. there?
Today FRESEN.MED.CARE KGAA O.N. has the market capitalization of 12.01 B, it has increased by 2.64% over the last week.
Yes, you can track FRESEN.MED.CARE KGAA O.N. financials in yearly and quarterly reports right on TradingView.
FRESEN.MED.CARE KGAA O.N. is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
FME earnings for the last quarter are 0.82 EUR per share, whereas the estimation was 0.71 EUR resulting in a 15.40% surprise. The estimated earnings for the next quarter are 0.87 EUR per share. See more details about FRESEN.MED.CARE KGAA O.N. earnings.
FRESEN.MED.CARE KGAA O.N. revenue for the last quarter amounts to 4.82 B EUR, despite the estimated figure of 4.95 B EUR. In the next quarter, revenue is expected to reach 5.48 B EUR.
FME net income for the last quarter is 213.03 M EUR, while the quarter before that showed 187.03 M EUR of net income which accounts for 13.90% change. Track more FRESEN.MED.CARE KGAA O.N. financial stats to get the full picture.
Yes, FME dividends are paid annually. The last dividend per share was 1.19 EUR. As of today, Dividend Yield (TTM)% is 2.91%. Tracking FRESEN.MED.CARE KGAA O.N. dividends might help you take more informed decisions.
FRESEN.MED.CARE KGAA O.N. dividend yield was 3.13% in 2023, and payout ratio reached 69.97%. The year before the numbers were 3.66% and 48.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has 119.84 K employees. See our rating of the largest employees — is FRESEN.MED.CARE KGAA O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESEN.MED.CARE KGAA O.N. EBITDA is 3.18 B EUR, and current EBITDA margin is 16.45%. See more stats in FRESEN.MED.CARE KGAA O.N. financial statements.
Like other stocks, FME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESEN.MED.CARE KGAA O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESEN.MED.CARE KGAA O.N. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESEN.MED.CARE KGAA O.N. stock shows the neutral signal. See more of FRESEN.MED.CARE KGAA O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.